Results 11 to 20 of about 127,738 (207)
NATURALLY OCCURRING AND SYNTHETIC IMMUNOMODULATORS WITH DIFFERENT BIOLOGICAL ACTIVITIES: LITERATURE SURVEY AND HISTORICAL INSIGHT [PDF]
Al-Azhar Journal of Pharmaceutical Sciences, 2021 An immunomodulator is a substance that stimulates or suppresses the immune system and may help the body fight cancer. The aim of this review is to highlight results of research done on immunomodulators of natural or synthetic origin showing different ...
Mohamed El-Zahabi
doaj +1 more source
Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment [PDF]
Cancers, 2020 Francesco Albano +2 more
exaly +2 more sources
Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Pharmaceuticals, 2023 Glaucoma, a group of diseases characterized by progressive retinal ganglion cell loss, cupping of the optic disc, and a typical pattern of visual field defects, is a leading cause of severe visual impairment and blindness worldwide.
Francesco Buonfiglio +2 more
doaj +1 more source
Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
Antibiotics, 2022 Fungal infections have become a growing public health challenge due to the clinical transmission of pathogenic fungi. The currently available antifungal drugs leave very limited choices for clinical physicians to deal with such situation, not to mention ...
Hua Zhong, Lei Han, Ren-Yi Lu, Yan Wang
doaj +1 more source
Research Progress on Immunoregulation of Chemotherapeutic Agents
Zhongliu Fangzhi Yanjiu, 2022 Chemotherapeutic drugs are the mainstay of treatment on mid-advanced tumors. In recent years, more and more studies have shown that chemotherapeutic drugs also have immunomodulatory effects.
LIU Zhenghao, YANG Chunguang, HU Zhiquan
doaj +1 more source
Potential therapies against SARS-CoV-2 virus evaluated in large-scale clinical trials [PDF]
Romanian Journal of Pharmaceutical Practice, 2022 COVID-19 is a viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The pathogenesis of SARS-CoV-2 infection in humans manifests as mild symptoms to severe respiratory failure.
Alin-Viorel Focsa +4 more
doaj +1 more source
Cells, 2023 Retinoid X receptor (RXR) heterodimerizes with the PPAR nuclear hormone receptor and regulates its downstream events. We investigated the effects of RXR agonists (LG100754, bexarotene, AGN194204, and LG101506) on lenalidomide’s anti-myeloma activity, T ...
Jian Wu +4 more
doaj +1 more source
Haematologica, 2018 The immunomodulatory drugs, lenalidomide and pomalidomide yield high response rates in multiple myeloma patients, but are associated with a high rate of thrombocytopenia and increased risk of secondary hematologic malignancies.
Ailing Liu +10 more
doaj +1 more source
Pomalidomide for Treatment of Relapsed and Refractory Multiple Myeloma
Клиническая онкогематология, 2015 Pomalidomide is a third-generation immunomodulatory drug recommended for patients with multiple myeloma refractory to lenalidomide and bortezomib. The safety profile is optimized for application in patients with intensive and continuous anti-tumor ...
Sergei Vyacheslavovich Semochkin
doaj +1 more source
Molecules, 2020 Immunomodulatory drugs (IMiDs) are used in the treatment of hematological malignancies, especially multiple myeloma. IMiDs have direct anticancer effects but also indirect effects via cancer-supporting stromal cells.
Ida Marie Rundgren +4 more
doaj +1 more source